Arnav Srivastava

12PUBLICATIONS
15CO-AUTHORS
Pharmaceutical delivery technologiesPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Other creative arts and writing not elsewhere classifiedTe ariā o ngā tauira panoni hauora o te Māori (Māori theory of change models for health)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 11, 2026
Impact of In-Office Dispensing Adoption by Urology Practices on Oral Specialty Drug Use in Advanced Prostate Cancer.

Kassem S Faraj, Mary Oerline, Samuel R Kaufman

|Nov 12, 2025
A prospective study of minimal residual disease in urological cancers using circulating tumour DNA.

Arnav Srivastava, Derrian Cooley, Steven M Monda

|Aug 29, 2025
Anticipated Out-Of-Pocket Costs and Prostate Cancer Management Among Men With Commercial Insurance.

Sarah Leick, Addison Shay, Samuel R Kaufman

|Jul 10, 2025
Differences in the Use and Quality of Active Surveillance for Prostate Cancer Among Men Insured by Medicaid.

Arnav Srivastava, Stephanie Daignault-Newton, Sabir Meah

|Mar 27, 2025
Editorial Comment.

Kristin Weiss, Arnav Srivastava

|Mar 20, 2025
Spillover Effects of Medicare Advantage on Traditional Medicare Beneficiaries With Prostate Cancer.

Arnav Srivastava, Samuel R Kaufman, Xiu Liu

Pageof 2

Frequent Collaborators

2 joint publications

Thomas L Jang

2 joint publications

Addison Shay

2 joint publications

Kassem S Faraj

2 joint publications

Paula Guro